Skip to product information
1 of 3

URAT1 Recombinant Rabbit mAb

URAT1 Recombinant Rabbit mAb

Catalog Number: S0B60376 Application: WB Reactivity: Hu, Ms, Rt Conjugation: Unconjugated Brand: Starter
Price:
Regular price $100 USD
Regular price Sale price $100 USD
Size:

For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Host Rabbit
Antigen URAT1
Synonyms Solute carrier family 22 member 12; Organic anion transporter 4-like protein; Renal-specific transporter (RST); Urate anion exchanger 1 (URAT1); Urate:anion antiporter SLC22A12; OATL4; SLC22A12
Location Cell membrane
Accession Q96S37
Antibody Type Recombinant mAb
Isotype IgG
Application WB
Reactivity Hu, Ms, Rt
Positive Sample HeLa, mouse kidney, rat kidney
Purification Protein A
Concentration 1 mg/ml
Conjugation Unconjugated
Physical Appearance Liquid
Storage Buffer

PBS, 40% Glycerol, 0.05% BSA, 0.02% sodium azide

Stability & Storage

12 months from date of receipt / reconstitution, -20 °C as supplied

Dilution


application dilution species
WB 1:1000-1:10000 Hu, Ms, Rt

Background

URAT1 (Urate Transporter 1), encoded by the SLC22A12 gene, is a critical transmembrane protein predominantly expressed on the apical membrane of proximal tubule epithelial cells in the kidney, where it functions as the primary mediator of renal urate reabsorption by facilitating the exchange of intracellular dicarboxylates or monocarboxylates for luminal uric acid. As a key determinant of serum uric acid homeostasis, URAT1 activity directly influences circulating urate levels, and loss-of-function mutations in this transporter are causally linked to idiopathic renal hypouricemia, whereas its overactivity contributes to hyperuricemia and gout pathogenesis. Consequently, URAT1 has emerged as a major pharmacological target for uricosuric therapies, with drugs such as benzbromarone, probenecid, lesinurad, and dotinurad specifically designed to inhibit this transporter’s function, thereby enhancing urinary uric acid excretion and lowering serum urate concentrations in patients with gout and hyperuricemia.

Picture

Western Blot

WB result of URAT1 Recombinant Rabbit mAb
Primary antibody: URAT1 Recombinant Rabbit mAb at 1/10000 dilution
Lane 1: HeLa whole cell lysate 20 µg
Secondary antibody: Goat Anti-rabbit IgG (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 60 kDa
Observed MW: 80 kDa
This blot was developed with high sensitivity substrate

WB result of URAT1 Recombinant Rabbit mAb
Primary antibody: URAT1 Recombinant Rabbit mAb at 1/10000 dilution
Lane 1: mouse kidney lysate 20 µg
Secondary antibody: Goat Anti-rabbit IgG (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 60 kDa
Observed MW: 80 kDa
This blot was developed with high sensitivity substrate

WB result of URAT1 Recombinant Rabbit mAb
Primary antibody: URAT1 Recombinant Rabbit mAb at 1/10000 dilution
Lane 1: rat kidney lysate 20 µg
Secondary antibody: Goat Anti-rabbit IgG (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 60 kDa
Observed MW: 80 kDa
This blot was developed with high sensitivity substrate